Protocol adherence and safety of intravenous thrombolysis after telephone consultation with a stroke center.
暂无分享,去创建一个
L. Wechsler | M. Hammer | T. Jovin | K. Uchino | L. Massaro
[1] G. Moneta,et al. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke , 2009 .
[2] Ronald G. Thomas,et al. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study , 2008, The Lancet Neurology.
[3] L. Pettigrew,et al. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: Safety outcome in rural hospitals , 2008, Clinical Neurology and Neurosurgery.
[4] Bernadette Boden-Albala,et al. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. , 2007, Annals of emergency medicine.
[5] Adnan I. Qureshi,et al. Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .
[6] G. Albers,et al. Symptomatic Intracerebral Hemorrhage following Thrombolytic Therapy for Acute Ischemic Stroke: A Review of the Risk Factors , 2007, Cerebrovascular Diseases.
[7] P. Heuschmann,et al. Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany , 2006, The Lancet Neurology.
[8] L. McCullough,et al. The "drip-and-ship" approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center. , 2005, Connecticut medicine.
[9] California Acute Stroke Pilot Registry Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke , 2005 .
[10] M. Flaster,et al. tPA by telephone: Extending the benefits of a comprehensive stroke center , 2005, Neurology.
[11] P. Heuschmann,et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. , 2004, JAMA.
[12] Scott Hamilton,et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.
[13] Joseph P Broderick,et al. Eligibility for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Population-Based Study , 2004, Stroke.
[14] G. D. Graham,et al. Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice: A Meta-Analysis of Safety Data , 2003, Stroke.
[15] D. Summers,et al. Expanded Modes of Tissue Plasminogen Activator Delivery in a Comprehensive Stroke Center Increases Regional Acute Stroke Interventions , 2003, Stroke.
[16] M. Hammer,et al. Quality Improvement and Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Cleveland Update , 2003, Stroke.
[17] J. Concato,et al. Thrombolysis for acute stroke in routine clinical practice. , 2002, Archives of internal medicine.
[18] V. Hachinski,et al. Extending Tissue Plasminogen Activator Use to Community and Rural Stroke Patients , 2002, Stroke.
[19] S. Cramer,et al. Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals , 2001, Stroke.
[20] A. Furlan,et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. , 2000, JAMA.
[21] J. Milbrandt,et al. Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. , 2000, Stroke.
[22] L Bozzao,et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. , 1999, Stroke.
[23] J. Chalela,et al. Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke. , 1999, Stroke.
[24] J. Grotta,et al. Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. , 1996, Stroke.
[25] Koroshetz Wj,et al. Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.
[26] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .